MedTrace Logo

Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms

NCT06110702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 287

Last updated 2024-04-16

No results posted yet for this study

Summary

The Eye Movement Desensitization and Reprocessing Protocol (EMDR) was first developed by Francine Shapiro in 1987 and can be adapted for online and in presence administration. The aim of this study is to assess if a EMDR program (administered both online and in presence, depending on different conditions of patients) may help people recruited from general population suffering from COVID19 second (November 2021 to February 2022) and third (March 2022 to May 2022) quarantine in improving post-traumatic stress (PTSD) and obsessive-compulsive-related (OCD) symptoms, as well as disgust, guilt, shame and their subjective unit of distress (SUD) and validity of cognition (VoC) levels.

Conditions

  • Adult ALL
  • Post-traumatic Stress Disorder
  • Obsessive-Compulsive Disorder
  • Disgust
  • Guilt
  • Shame

Interventions

BEHAVIORAL

EMDR

Eye movement Desensitization and Reprocessing (as described in the 8-phases protocol), administered both online or in presence.

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Principal Investigators

  • Andrea Poli, PsyD · University of Pisa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-10
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06110702 on ClinicalTrials.gov